At a glance
ClinicalIndex Comparison RecordN/ACompleted· 36 enrolled
Drug / intervention
Boswellia Serrata +9 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Botanical Microglia Modulators in Gulf War Illness
In Brief
A clinical study evaluating Boswellia Serrata, Curcumin, and 8 other interventions for Gulf War Illness. Completed, enrolled 36 participants across 1 site.
Detailed Summary
The overall objective of this protocol is to test if Gulf War Illness (GWI) involves chronic inflammation that cannot be measured with typical techniques. The investigators will be observing the effects of nine different botanical compounds (supplements) that are known to suppress inflammation. If one of those supplements helps the symptoms of GWI, it will give the investigators information about what is wrong in people with GWI.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGulf War Illness
CountriesUnited States
CollaboratorsCongressionally Directed Medical Research Programs
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJul 2016
First PostedSep 2016
Primary CompletionSep 2019
Study CompletionSep 2022
TodayJul 2026
First PostedSep 21, 2016
Enrollment StartJul 1, 2016
Primary CompletionSep 1, 2019
Study CompletionSep 1, 2022
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 9.8 years ago
Interventions
Boswellia Serratadietary
Curcumindietary
Epimediumdietary
Fisetindietary
Luteolindietary
Nettledietary
Pycnogenoldietary
Reishi Mushroomdietary
Resveratroldietary
Placebodietary